Colorado PROFILES, The Colorado Clinical and Translational Sciences Institute (CCTSI)
Keywords
Last Name
Institution

Contact Us
If you have any questions or feedback please contact us.

Atsushi Oba

Concepts (248)

Concepts are derived automatically from a person's publications.

Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.

Name Number of Publications Most Recent Publication Publications by All Authors Concept Score Why?
Pancreatic Neoplasms
81
2026
944
13.470
Why?
Pancreatectomy
40
2026
289
6.350
Why?
Carcinoma, Pancreatic Ductal
22
2026
297
4.770
Why?
Robotic Surgical Procedures
16
2026
210
4.190
Why?
Liver Neoplasms
25
2026
776
4.080
Why?
Pancreaticoduodenectomy
29
2026
149
4.030
Why?
Hepatectomy
21
2026
256
3.040
Why?
Laparoscopy
13
2025
487
2.460
Why?
Neoadjuvant Therapy
21
2026
475
2.340
Why?
Mesenteric Artery, Superior
11
2026
28
1.910
Why?
Portal Vein
10
2025
123
1.860
Why?
Mesenteric Veins
6
2025
28
1.810
Why?
Bile Duct Neoplasms
8
2026
132
1.570
Why?
Colorectal Neoplasms
12
2025
874
1.510
Why?
Vascular Surgical Procedures
7
2025
352
1.470
Why?
Prognosis
38
2026
4351
1.430
Why?
Retrospective Studies
69
2026
17438
1.190
Why?
Japan
10
2026
149
1.170
Why?
Pancreas
9
2025
343
1.160
Why?
Antineoplastic Combined Chemotherapy Protocols
17
2025
1998
1.140
Why?
Gastrectomy
3
2025
164
1.140
Why?
CA-19-9 Antigen
7
2026
36
1.110
Why?
Gadolinium DTPA
3
2026
70
1.110
Why?
Aged
60
2026
26432
1.060
Why?
Deoxycytidine
9
2025
219
1.040
Why?
Celiac Artery
5
2023
19
1.000
Why?
Postoperative Complications
19
2026
3034
0.940
Why?
Adenocarcinoma
8
2026
927
0.920
Why?
Biliary Tract Surgical Procedures
2
2025
26
0.910
Why?
Robotics
2
2023
89
0.880
Why?
Humans
125
2026
146342
0.860
Why?
Middle Aged
55
2026
36619
0.850
Why?
Pancreatic Fistula
7
2025
35
0.850
Why?
Carcinoma, Hepatocellular
3
2021
370
0.830
Why?
Stomach Neoplasms
1
2025
128
0.810
Why?
Gastroenterology
2
2023
187
0.800
Why?
Gastric Stump
1
2023
1
0.790
Why?
Biomarkers, Tumor
9
2026
1339
0.790
Why?
Chemotherapy, Adjuvant
10
2026
429
0.760
Why?
Aged, 80 and over
19
2026
8391
0.730
Why?
Adenoma
2
2025
210
0.720
Why?
Survival Rate
15
2026
2092
0.720
Why?
Tegafur
3
2025
12
0.680
Why?
Oxonic Acid
3
2025
13
0.680
Why?
Nomograms
1
2022
59
0.670
Why?
Neoplasm Staging
8
2025
1488
0.660
Why?
Treatment Outcome
28
2026
11821
0.650
Why?
Female
62
2026
79499
0.640
Why?
Klatskin Tumor
3
2025
18
0.640
Why?
Neoplasm Recurrence, Local
7
2026
1160
0.630
Why?
Magnetic Resonance Imaging
3
2026
3926
0.630
Why?
Dissection
6
2026
58
0.630
Why?
Male
59
2026
73396
0.620
Why?
Cystadenoma, Serous
1
2020
18
0.620
Why?
Drainage
4
2026
187
0.620
Why?
Neuroendocrine Tumors
2
2023
122
0.610
Why?
Vascular Neoplasms
1
2020
19
0.610
Why?
Internationality
1
2020
156
0.600
Why?
Cystadenocarcinoma, Serous
1
2020
90
0.580
Why?
Practice Patterns, Physicians'
3
2025
1408
0.560
Why?
Duodenal Neoplasms
3
2023
26
0.550
Why?
Angiography
1
2018
206
0.530
Why?
Cholangiocarcinoma
3
2026
110
0.510
Why?
Adult
34
2026
41087
0.510
Why?
Neoplasm Invasiveness
6
2025
504
0.510
Why?
Patient Compliance
1
2021
589
0.500
Why?
Multidetector Computed Tomography
1
2017
40
0.500
Why?
Operative Time
6
2026
195
0.470
Why?
Thrombosis
2
2024
398
0.460
Why?
Biliary Tract Neoplasms
2
2025
30
0.440
Why?
Pneumonia, Viral
1
2020
387
0.440
Why?
Coronavirus Infections
1
2020
379
0.440
Why?
Fibrin Tissue Adhesive
2
2025
20
0.430
Why?
Polyglycolic Acid
2
2025
44
0.430
Why?
Surgical Mesh
2
2025
54
0.420
Why?
Common Bile Duct Neoplasms
2
2025
28
0.400
Why?
DNA Damage
1
2017
439
0.400
Why?
Ultrasonography
1
2018
788
0.400
Why?
Ampulla of Vater
2
2025
40
0.400
Why?
Proportional Hazards Models
5
2026
1331
0.390
Why?
Antineoplastic Agents
2
2021
2219
0.380
Why?
Neoplasms, Multiple Primary
2
2025
57
0.370
Why?
Precision Medicine
1
2016
462
0.350
Why?
Fluorouracil
7
2025
231
0.340
Why?
Contrast Media
3
2026
493
0.340
Why?
Diabetes Mellitus
3
2025
1101
0.340
Why?
Embolization, Therapeutic
2
2024
246
0.330
Why?
Blood Loss, Surgical
3
2026
117
0.320
Why?
Jejunum
3
2024
36
0.310
Why?
Paclitaxel
7
2025
260
0.310
Why?
Leucovorin
6
2025
98
0.310
Why?
Follow-Up Studies
11
2026
5439
0.310
Why?
Margins of Excision
2
2026
55
0.290
Why?
Diarrhea
3
2026
190
0.290
Why?
Minimally Invasive Surgical Procedures
3
2025
196
0.290
Why?
Transcription Factors
1
2017
1730
0.280
Why?
Sweden
2
2025
114
0.260
Why?
Disease-Free Survival
3
2025
778
0.260
Why?
Hepatic Veins
2
2024
28
0.250
Why?
Splenic Artery
2
2024
13
0.250
Why?
Antigens, Neoplasm
2
2026
271
0.250
Why?
Incisional Hernia
1
2026
8
0.240
Why?
Abdominal Wound Closure Techniques
1
2026
8
0.240
Why?
Carcinoma in Situ
1
2026
45
0.240
Why?
Fasciotomy
1
2026
24
0.240
Why?
Collateral Circulation
1
2025
20
0.230
Why?
Albumins
5
2025
120
0.230
Why?
Hemostasis, Surgical
1
2025
25
0.230
Why?
Peritoneal Lavage
1
2025
8
0.230
Why?
Renal Veins
1
2025
16
0.230
Why?
Leiomyosarcoma
1
2025
30
0.230
Why?
Clinical Decision-Making
2
2020
365
0.230
Why?
Surgical Stapling
1
2025
14
0.230
Why?
Anatomic Landmarks
1
2025
31
0.220
Why?
Abdominal Neoplasms
1
2025
48
0.220
Why?
Pericardium
1
2025
59
0.220
Why?
Vena Cava, Inferior
1
2025
80
0.220
Why?
Splenomegaly
1
2024
15
0.220
Why?
Surgery, Computer-Assisted
1
2025
87
0.210
Why?
Caveolin 1
1
2024
20
0.210
Why?
Chemoradiotherapy
2
2025
238
0.210
Why?
Induction Chemotherapy
1
2024
87
0.210
Why?
Adenocarcinoma, Mucinous
2
2022
76
0.200
Why?
Age Factors
2
2022
3347
0.200
Why?
Liver Failure
1
2024
79
0.200
Why?
Metastasectomy
1
2024
19
0.200
Why?
Succinimides
1
2023
21
0.200
Why?
Drug Combinations
3
2025
400
0.190
Why?
Nutritional Status
1
2025
346
0.190
Why?
Cohort Studies
4
2024
6077
0.180
Why?
Pancreaticojejunostomy
1
2022
8
0.180
Why?
Cholestasis
2
2022
217
0.180
Why?
Preoperative Care
1
2025
396
0.180
Why?
Adenocarcinoma, Papillary
1
2022
11
0.180
Why?
Anastomosis, Surgical
4
2023
164
0.180
Why?
Feasibility Studies
5
2025
1135
0.180
Why?
Imaging, Three-Dimensional
1
2025
582
0.170
Why?
Postoperative Hemorrhage
1
2023
106
0.170
Why?
Hemangiosarcoma
1
2022
27
0.170
Why?
Carcinoma
1
2023
225
0.170
Why?
Spleen
1
2023
503
0.170
Why?
Tomography, X-Ray Computed
3
2026
2786
0.160
Why?
Antigens, Tumor-Associated, Carbohydrate
1
2020
8
0.160
Why?
Tumor Burden
1
2022
326
0.160
Why?
Surgeons
1
2025
351
0.160
Why?
Portal System
1
2020
12
0.160
Why?
Stents
2
2022
554
0.150
Why?
Ischemia
1
2023
421
0.150
Why?
Predictive Value of Tests
3
2025
2113
0.150
Why?
Hepatic Artery
1
2020
53
0.150
Why?
Benchmarking
1
2020
193
0.150
Why?
Orotate Phosphoribosyltransferase
1
2018
3
0.140
Why?
Indocyanine Green
1
2018
43
0.140
Why?
Biology
3
2024
90
0.140
Why?
Consensus
1
2020
467
0.140
Why?
Lymph Nodes
2
2023
511
0.140
Why?
Fluorescence
1
2018
160
0.140
Why?
Multivariate Analysis
2
2023
1543
0.130
Why?
Intraoperative Care
1
2018
68
0.130
Why?
Betacoronavirus
1
2020
288
0.130
Why?
Risk Factors
5
2026
10921
0.130
Why?
Lymph Node Excision
3
2024
174
0.120
Why?
Comorbidity
1
2022
1665
0.120
Why?
Patient Safety
1
2020
352
0.120
Why?
Practice Guidelines as Topic
1
2024
1591
0.120
Why?
Fluorocarbons
1
2018
122
0.120
Why?
Hospitals, University
1
2016
178
0.110
Why?
Biopsy, Needle
1
2016
183
0.110
Why?
Immunohistochemistry
2
2018
1712
0.110
Why?
Sex Factors
1
2022
2107
0.110
Why?
Hypoglycemic Agents
1
2025
1412
0.110
Why?
Statistics, Nonparametric
1
2016
426
0.110
Why?
Incidence
3
2026
2936
0.110
Why?
Cell Survival
1
2018
1105
0.110
Why?
Gene Expression Regulation, Neoplastic
1
2020
1432
0.110
Why?
DNA Repair
1
2017
255
0.100
Why?
Liver
1
2023
1864
0.100
Why?
Insulin
1
2025
2525
0.100
Why?
Ultraviolet Rays
1
2017
376
0.100
Why?
Ligation
2
2024
88
0.100
Why?
Reactive Oxygen Species
1
2017
610
0.100
Why?
Prospective Studies
3
2025
8123
0.100
Why?
Kaplan-Meier Estimate
1
2016
970
0.100
Why?
Health Care Surveys
2
2025
541
0.100
Why?
Carcinoembryonic Antigen
2
2023
40
0.100
Why?
Young Adult
2
2022
14330
0.090
Why?
Breast Neoplasms
1
2025
2418
0.090
Why?
Thyrotropin
2
2024
120
0.090
Why?
Splenectomy
2
2023
61
0.090
Why?
Time Factors
4
2026
7109
0.090
Why?
Computational Biology
1
2017
678
0.090
Why?
Patient Selection
1
2016
728
0.090
Why?
Surveys and Questionnaires
2
2025
6073
0.090
Why?
Pandemics
1
2020
1707
0.090
Why?
Mutation
2
2023
4093
0.080
Why?
Lung Neoplasms
1
2023
2675
0.080
Why?
Reproducibility of Results
1
2018
3416
0.080
Why?
Cell Line, Tumor
1
2017
3545
0.070
Why?
Apoptosis
1
2017
2439
0.070
Why?
Hospital Mortality
2
2024
1051
0.070
Why?
Length of Stay
2
2025
1358
0.060
Why?
Polydioxanone
1
2026
5
0.060
Why?
Risk Assessment
1
2016
3712
0.060
Why?
Organoplatinum Compounds
1
2025
65
0.060
Why?
Cytodiagnosis
1
2025
31
0.060
Why?
Suture Techniques
1
2026
138
0.050
Why?
Preoperative Period
1
2025
157
0.050
Why?
Tissue Adhesives
1
2024
21
0.050
Why?
Pancreatitis
1
2025
146
0.050
Why?
Neoplasm, Residual
1
2025
143
0.050
Why?
Pneumonectomy
1
2026
169
0.050
Why?
United States
1
2021
16136
0.050
Why?
Smad4 Protein
1
2023
33
0.050
Why?
Hepatic Duct, Common
1
2023
5
0.050
Why?
Cyclin-Dependent Kinase Inhibitor p16
1
2023
74
0.050
Why?
Cattle
1
2025
940
0.050
Why?
Multicenter Studies as Topic
1
2024
417
0.050
Why?
Bile Ducts, Intrahepatic
1
2023
62
0.050
Why?
Propensity Score
1
2025
376
0.050
Why?
Reoperation
1
2025
645
0.050
Why?
Abdomen
1
2023
142
0.050
Why?
Postoperative Care
1
2024
301
0.040
Why?
Adolescent
1
2022
22557
0.040
Why?
Proto-Oncogene Proteins p21(ras)
1
2023
250
0.040
Why?
Neoplasm Metastasis
1
2024
693
0.040
Why?
Combined Modality Therapy
1
2024
1271
0.040
Why?
Lymphatic Metastasis
1
2022
335
0.040
Why?
Survival Analysis
1
2024
1378
0.040
Why?
Stomach
1
2021
106
0.040
Why?
Plastics
1
2021
50
0.040
Why?
Intention to Treat Analysis
1
2020
78
0.040
Why?
Reproduction
1
2022
209
0.040
Why?
Europe
1
2021
421
0.040
Why?
Morbidity
1
2021
319
0.040
Why?
Colectomy
1
2020
119
0.040
Why?
Tumor Suppressor Protein p53
1
2023
530
0.040
Why?
Safety
1
2021
347
0.040
Why?
Equilibrative Nucleoside Transporter 1
1
2018
19
0.040
Why?
Randomized Controlled Trials as Topic
1
2024
1763
0.030
Why?
Colonic Neoplasms
1
2020
259
0.030
Why?
Recurrence
1
2021
1133
0.030
Why?
Disease Progression
1
2023
2867
0.030
Why?
Blood Glucose
1
2025
2360
0.030
Why?
Gene Expression
1
2018
1463
0.020
Why?
Palliative Care
1
2022
1032
0.020
Why?
Lung
1
2023
4122
0.020
Why?
Analgesics, Opioid
1
2018
1221
0.020
Why?
Animals
1
2025
38107
0.010
Why?
Oba's Networks
Click the "See All" links for more information and interactive visualizations!
Concepts Expand Description
_
Co-Authors Expand Description
_
Similar People Expand Description
_
Same Department Expand Description

Copyright © 2026 The Regents of the University of Colorado, a body corporate. All rights reserved. (Harvard PROFILES RNS software version: 2.11.1)